Search Results for citation:"90 FR 16691"

Found 1 results
Skip to main content

Search Results: citation:"90 FR 16691"

  • Type:Notice
    Citation:90 FR 16691
    Reading Time:about 3 minutes

    The Food and Drug Administration (FDA) determined that MOBIC (meloxicam) tablets, available in 7.5 mg and 15 mg doses, were not withdrawn from sale because of safety or effectiveness concerns. This means that the FDA will continue to approve generic versions of this medicine as long as they meet all legal and regulatory requirements. MOBIC is used to treat arthritis symptoms and is now listed in the "Discontinued Drug Product List," but this listing does not imply any safety issues. The FDA will ensure that any needed updates to the drug's labeling are made.

    Simple Explanation

    MOBIC is a medicine that helps with arthritis and the people in charge, called the FDA, checked and said it wasn't stopped for being bad or not working. This means other companies can still make similar pills if they follow the rules.